Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1461-1470 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|December 22, 2022
Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signalingNicholas R Anderson, Vipul Sheth, Hui Li, et al.
Leukemia|December 6, 2022
CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress responseJonas S Jutzi, Anna E Marneth, María José Jiménez-Santos, et al.
Leukemia|December 13, 2022
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCLShaoying Li, Lianqun Qiu, Jie Xu, et al.
Leukemia|November 24, 2019
Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosisEli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, et al.
Leukemia|November 27, 2019
Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantationAnne Bouvier, Jérémie Riou, Sylvain Thépot, et al.
Leukemia|November 28, 2019
Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphomaDashnamoorthy Ravi, Saheli Sarkar, Sneha Purvey, et al.
Leukemia|November 16, 2019
Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasmsJulian Baumeister, Nicolas Chatain, Annika Hubrich, et al.
Leukemia|October 1, 1988
bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemiaA Hermans, J Gow, L Selleri, et al.
Leukemia|October 1, 1988
Clinical characteristics of infant acute leukemia with or without 11q23 translocationsY Kaneko, T Shikano, N Maseki, et al.
Leukemia|October 1, 1988
Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cellsO G Ottmann, K H Nocka, M A Moore, et al.
Pageof 963

Showing results (1461-1470 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|December 22, 2022
Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signalingNicholas R Anderson, Vipul Sheth, Hui Li, et al.
Leukemia|December 6, 2022
CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress responseJonas S Jutzi, Anna E Marneth, María José Jiménez-Santos, et al.
Leukemia|December 13, 2022
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCLShaoying Li, Lianqun Qiu, Jie Xu, et al.
Leukemia|November 24, 2019
Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosisEli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, et al.
Leukemia|November 27, 2019
Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantationAnne Bouvier, Jérémie Riou, Sylvain Thépot, et al.
Leukemia|November 28, 2019
Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphomaDashnamoorthy Ravi, Saheli Sarkar, Sneha Purvey, et al.
Leukemia|November 16, 2019
Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasmsJulian Baumeister, Nicolas Chatain, Annika Hubrich, et al.
Leukemia|October 1, 1988
bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemiaA Hermans, J Gow, L Selleri, et al.
Leukemia|October 1, 1988
Clinical characteristics of infant acute leukemia with or without 11q23 translocationsY Kaneko, T Shikano, N Maseki, et al.
Leukemia|October 1, 1988
Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cellsO G Ottmann, K H Nocka, M A Moore, et al.
Pageof 963